publication date: Jan. 22, 2016

Willson Named CPRIT Chief Scientific Officer 

 

JAMES WILLSON was named chief scientific officer of the Cancer Prevention and Research Institute of Texas, effective March 1. Willson is the associate dean of oncology programs, and professor and director of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center.

Willson led UT Southwestern’s successful efforts to have the Simmons Cancer Center recognized with comprehensive status from NCI, the institute’s highest designation, according to the university.

“I was attracted to this position because it provides an opportunity to expand the frontiers of cancer research by encouraging new discoveries with real potential to transform the way cancer is treated,” said Willson, who holds The Lisa K. Simmons Distinguished Chair in Comprehensive Oncology at UT Southwestern. “I look forward to building on the exceptional contributions and high standards of excellence of my predecessors – Drs. Margaret Kripke and Al Gilman.”

As chief scientific officer at CPRIT, Willson will lead the agency’s academic research program in supporting its research and recruiting cancer researchers to Texas institutions.

To date, CPRIT has awarded 806 academic research grants totaling $1.046 billion, and CPRIT funding has helped hire 104 cancer researchers in Texas.

“Dr. Willson has provided outstanding leadership as Director of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern, as reflected in the enormous growth of both its groundbreaking research program and superb care for cancer patients,” said Daniel Podolsky, president of UT Southwestern.

“CPRIT and the State of Texas are fortunate that Dr. … Continue reading 42-03 Willson Named CPRIT Chief Scientific Officer

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.